about equal (-2.8 t o~t a l l stature (4 m, 4 f), R and T were better than BP. In precocious puberty (4 m, 3 f), BP was accurate (1.8 cm), but R and T grossly overestimated at 10 years CA (20.9 and 27.5 cm). In Turner's s ndrome (4 f), all overestimated at 9 years, R and T .
* . i ' c m ) than BP (2.2 cm). The same was found in ~rimordial dwarfism (4 f) and Russell-Silver syndrome (3 m). It is concluded that R and T give better overall results, if bone age does not deviate more than about f 2 years from CA. In conditions with larger differences, BP is more accurate.
LDI~VID, E. de PERETTI, A. EVRARW, J. BERTRAND, Delayed growth and adolescence (D.c.A.) with l a c k of adrenarche : catch-up of growth with dehydroepiandrosterone s u l f a t e (DIWS) therapy. W e have good evidence that t h e r e a r e 2 main t y p e s of DGA :
i n type I growth and bone age (BA) v e l o c i t i e s u s u a l l y slow down between 6/8 y e a r s ( y ) , sometimes e a r l i e r , i n c h i l d r e n who o f t e n have s h o r t s t a t u r e ; i n type I1 t h e decrease of growth and BA s t a r t s between 12/13 y i n g i r l s and 13/14 y i n boys. A l a c k of adrenarche a s i n d i c a t e d by low plasma l e v e l s of dehydroepizndrosterone (DHA) i s present i n t y p d ; normal adrenarche i s present i n type I1 a s i n hypogonadotro. phic hypogonadism. To t e s t t h e @ p o t h e s i s that t h e l a c k of adrenarche i s responsible f o r t h e DCL i n type I we s t u d i e d t h e e f f e c t of DILU therapy i n a 12 y o l d g i r l with t y p i c a l type I. Except f o r c o n s i s t e n t l y low plasma l e v e l s of DIW : 10 t o 22 ng/dl, a l l endocrine f u n c t i o n s were normal. DHAS was given a s a s i n g l e o r a l morning dose of 5 mg/day f o r one y : growth v e l o c i t y increased from 3.5 t o 9 with a growth over 3 A v e l o c i t i e s r a t i o = 1.3. From t h i s preliminary study we suggest t h a t a lack of adrenarche i s respons i b l e f o r t h e delayed maturation i n DGA type I and that o r a l DILLS could be a u s e f u l s u b s t i t u t i v e therapy.
M. RANKE* and J.R. BIERICH. 1 5 Dept. of Diagnostic Endocrinology, University, Children's Hospital, Tubingen, Germany. Comparison of circulating human growth hormone measured by radioimmunoassay (RIA) and radioreceptorassay (RRA) in plasma of children.
The binding characteristics of cultured human lymphocytes-IM9 in a plasmafree sample have been already definied (1). A modification of the original RRA method with IM-9 cells allows measurements of hGH in plasma at concentrations above 3.5 nglml (sensitivity of the RIA approx. 0.5 ng/ml) using only 0.1 ml plasma. A parallel study of hGH by RRA and RIA was carried out in 41 GH-deficient but receiving 4 I. 
i t s s u l f a t e (DHAS), 17-hydroxyprogesterone (OHP) and c o r t i s o l (F) l e v e l s i n panhypopit u i t a r i s m (group I ) and i s o l a t e d GH d e f i c i e n c y (group 11) :
Evidence f o r a p i t u i t a r y hormone c o n t r o l l i n g adrenal androgens b i o s y n t h e s i s .
Ten s u b j e c t s of g r o u p 1 (10-22 y e a r s ) were studied i n cornparison of I 1 s u b j e c t s of group I1 (8-15 y e a r s ) . In group I1 normal ACTH production was documented on ACTH l e v e l s and normal responses t o Metyrapone. As expected, adrenal androgens (DM, DHAS) a s w e l l a s OW and F were extremely low i n group I, r e f l e c t i n g t h e secondary adrenal i n s u f f i c i e n c y . I n c o n t r a s t group I1 had normal F and OW b a s a l l e v e l s f o r pub e r t a l s t a g e b u t on t h e c r i t e r i a of adrenal androgens lev e l s , 3 subgroups were found : DHA, DHAS were e i t h e r normal f o r age (A : 2 g i r l s 12-14 y r s ) o r low f o r age but consist e n t with delayed adrenarche (B : 3 boys 15-19 y r s ) o r drast i c a l l y low whatever age o r p u b e r t a l s t a g e ( C : 3 g i r l s 8-16 y r s ; 3 boys 8-13 y r s ) . Thus i n 112 of group I1 with appar e n t l y only GH d e f i c i e n c y but normal ACTH l e v e l s , impaired adrenal androgen production was documented. This suggests t h a t a p i t u i t a r y t r o p h i c hormone, lacking i n s u b j e c t s of subgroup 11-C, c o n t r o l s t h e adrenal androgen production.
J. M. PARKIN* and B. MORA* ( I n t r . by C.G.D. Brook)
17 Department of Child Health and Medicine, .
U n i v e r s i t y of Newcastle upon Tyne, England. m o i d Function during human growth hormone treatment.
Impairment of t h p o i d f u n c t i o n h a s been r e p o r t e d i n growth hormone d e f i c i e n t c h i l d r e n being t r e a t e d with human growth hormone, and t h e r e i s evidence t h a t this i s t h e r e s u l t of i n h i b i t i o n of t h e TSH response t o TRH. Basal TSH l e v e l s and the TSH l e v e l s 20 minutes a f t e r an i n j e c t i o n of TRH were normal i n e v e r y case. In o n l y one p a t i e n t was t h e serum thyroxine l e v e l low and in this p a t i e n t t h e growth response t o human growth hormone was v e r y good. It i s concluded t h a t t h e regime of treatment with humen growth hormone recommended by t h e Medical Research Council does n o t s i g n i f i c a n t l y a f f e c t t h y r o i d function.
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